Ginsenoside F1

(3β,6α,12β)-3,6,12-Trihydroxydammar-24-en-20-yl β-D-glucopyranoside

(3β,6α,12β)-3,6,12-Trihydroxydammar-24-en-20-yl-β-D-glucopyranosid

20(S)-ginsenoside F1

53963-43-2

Ginsenoside F1

MFCD06410947

panaxoside A progenin

β-D-Glucopyranoside de (3β,6α,12β)-3,6,12-trihydroxydammar-24-én-20-yle

β-D-Glucopyranoside, (3β,6α,12β)-3,6,12-trihydroxydammar-24-en-20-yl

(20S)-ginsenoside F1

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(((S)-6-methyl-2-((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)hept-5-en-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol

(3b,6a,12b)-3,6,12-Trihydroxydammar-24-en-20-yl b-D-glucopyranoside

(3b,6a,12b)-3,6,12-Trihydroxydammar-24-ene-20-yl β-D-glucopyranoside

(β,6α,12β)-3,6,12-trihydroxydammar-24-en-20-yl β-D-glucopyranoside